Don’t forget you can visit MyAlerts to manage your alerts at any time.
By Sue Reisinger | October 23, 2017
Former Bio-Rad GC Sanford Wadler won a whistleblower suit earlier this year against the company.
1 minute read
By Kristen Rasmussen | Corporate Counsel | October 17, 2017
Medical device company Boston Scientific Corp. has appointed Desiree Ralls-Morrison its new general counsel.
1 minute read
By Scott Graham | The Recorder | October 10, 2017
Lee will teach a course at Stanford Law that explores how IP laws and government policies shape innovation.
1 minute read
By Kristen Rasmussen | October 9, 2017
Calithera BioSciences Inc. has hired Sumita Ray as senior vice president, general counsel and chief compliance officer. Ray's practice will focus on U.S. Food and Drug Administration regulatory law, global health care and compliance, brand support and product launches, collaborations and alliances.
1 minute read
By Alexa Woronowicz | October 2, 2017
Hasko structured a pair of major strategic licensing deals for life sciences clients Seres and Aimmune.
1 minute read
By Ed Silverstein | September 28, 2017
Speculation builds as the FDA announced this week that Apple was one of nine companies the agency has approved for a pilot Digital Health Software Precertification program.
1 minute read
By Anna Zhang | September 25, 2017
Lawyers specializing in regulatory matters related to the Committee on Foreign Investment in the United States are having a busy year—especially with transactions related to Chinese investors.
1 minute read
By Gerard P. Norton and Michael S. Montgomery | September 18, 2017
On June 12, the U.S. Supreme Court issued a unanimous opinion in 'Sandoz v. Amgen,' a highly anticipated case concerning key provisions of the Biologics Price Competition and Innovation Act, part of the larger Patient Protection and Affordable Care Act of 2009.
1 minute read
By newyorklawjournal | New York Law Journal | September 6, 2017
Motions to Dismiss Denied Where Discovery On Defendants' Forum Contacts Necessary
1 minute read
By Kristen Rasmussen | September 6, 2017
Two top pharmaceutical trade groups have asked a federal judge to block a Nevada law requiring certain diabetes drugmakers to disclose information to the state about the cost of making and marketing the medications.
1 minute read
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Seeking a compassionate and experienced estate administration attorney for growing boutique estate planning and elder law practice. Huge eq...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS